1. Introduction {#sec1-nutrients-10-00811}
===============

Gastrointestinal symptoms (GIS) are widely reported in athletes participating in prolonged endurance events including; cyclists, triathletes and marathon runners, although there is a large estimated range of between 4--96% of participants affected \[[@B1-nutrients-10-00811]\]. These symptoms can have a number of aetiologies, including underlying pathology such as inflammatory bowel disease, the physiological changes that occur with exercise such as the reduction of splanchnic blood flow, changes to the physiology of digestion and transit, and the gut--brain axis \[[@B1-nutrients-10-00811]\]. Numerous potential factors may explain the large variance in reported symptoms such as the mode, duration or intensity of exercise, environmental conditions, nutritional intake, type of assessment tool, and method used to classify a "symptom". For example, studies have used 4, 9, 10, and 11-point scales, each with differing vernacular, to quantify GIS \[[@B2-nutrients-10-00811],[@B3-nutrients-10-00811],[@B4-nutrients-10-00811],[@B5-nutrients-10-00811]\]. Positive responses, of any magnitude, including those that do not affect performance, could be seen to overestimate the prevalence of symptoms, or may lead to erroneous conclusions regarding symptom severity. For example, studies that have reported data for GIS in marathon runners without acknowledging severity have shown prevalence rates of 52% and 71% \[[@B6-nutrients-10-00811],[@B7-nutrients-10-00811]\]. Contrarily, when symptoms were described as 'moderate' or 'serious' in severity, prevalence has been reported as 4--7% \[[@B2-nutrients-10-00811],[@B3-nutrients-10-00811]\]. Furthermore, symptom severity in the scales used is a subjective measure and not further quantified by, for example, duration or impact on performance. It is, therefore, clear that there is a need to better assess both the frequency and severity of GIS during a marathon race.

One potential cause of GIS during marathon running is nutritional intake before and/or during the race. Carbohydrate (CHO) intake in both the days before and during endurance exercise has been shown to be beneficial to performance \[[@B8-nutrients-10-00811],[@B9-nutrients-10-00811]\] yet there appears to be an association between carbohydrate intake during endurance exercise and GIS \[[@B10-nutrients-10-00811],[@B11-nutrients-10-00811],[@B12-nutrients-10-00811]\]. The mechanisms through which this may occur include potential malabsorption leading to luminal distension, delayed gastric emptying and gas production \[[@B13-nutrients-10-00811],[@B14-nutrients-10-00811]\]. It has been shown that reducing GIS associated with CHO intake during exercise was associated with improvements in performance \[[@B10-nutrients-10-00811]\]. However, to date, there has been little research into habitual dietary intake of recreational marathon runners, and their association with GIS during a race. The aim of the present study was to document the dietary intake and prevalence and severity of GIS during training in the week before a marathon and during a marathon and to investigate any association between them.

2. Methods {#sec2-nutrients-10-00811}
==========

2.1. Marathon Runners {#sec2dot1-nutrients-10-00811}
---------------------

Runners registered to participate in the 2017 Rock n Roll Liverpool and SSE Airtricity Dublin marathons were invited to participate in this study via email sent out by the race organisers. Informed consent to participate was provided through registration via an internet-based online data collection tool. A total of 216 runners across both races registered to participate, with 100 of these runners completing the online questionnaire. Of these, four participants did not provide sufficient detail to be included in the dataset. Characteristics of runners from each race are presented in [Table 1](#nutrients-10-00811-t001){ref-type="table"}. During the races, mean ambient temperatures were 16 °C and 12 °C and mean relative humidity was 80% and 82% for Liverpool and Dublin respectively. There was 0 mm of precipitation during both races. The race routes had total ascension and maximum elevations of 410 m and 72 m (Liverpool) and 120 m and 58 m (Dublin).

2.2. Experimental Design {#sec2dot2-nutrients-10-00811}
------------------------

One week before the marathon, participants were sent e-mail instructions in regard to the timing of subsequent communications, what information they would be asked to provide, and the importance of accuracy in all of their responses. Forty-eight hours before the race, a food diary template was sent to participants along with instructions on how to complete it, examples of completed food diaries, and images of different weights of common foods. Participants were required to prospectively record all food and fluid consumed in the 24 h before the race, as well as the morning of the race. For in-race nutrition, participants were informed that this information would be required, and to try to recall all in-race foods and fluids consumed. The information from food diaries, as well as in-race nutrition, were input into relevant sections of the questionnaire. The dietary information reported was analysed to quantify using Nutritics professional diet analysis software (Nutritics LTD, Dublin, Ireland) by two blinded, independent, and trained nutritionists.

2.3. Questionnaires {#sec2dot3-nutrients-10-00811}
-------------------

In the evening following the race, participants received an email link to the online questionnaire, and were asked to complete this as soon as possible. Reminder emails were sent 24 and 48 h later. Participants were required to report their age, gender, weight, height and details regarding their race history and training for the marathon. In order to differentiate between habitual GIS, and race specific GIS, participants completed a modified version of the Gastrointestinal Symptom Rating Scale (GSRS) \[[@B15-nutrients-10-00811]\], relating to the 7 days prior to the marathon, and then specifically symptoms during the marathon. The GSRS gives explanations of each symptom and was used as it has been shown to be understandable and has good reproducibility for measuring the presence of GIS compared to interviews \[[@B16-nutrients-10-00811]\]. This questionnaire has been previously used in large scale investigations \[[@B17-nutrients-10-00811],[@B18-nutrients-10-00811]\]. Symptoms include upper abdominal pain, epigastric pain, heartburn, regurgitation, abdominal rumbling, bloating, nausea, empty feeling in the stomach, early satiety, postprandial fullness, belching, flatulence, haematemesis, dysphagia, and questions on defecation. Subjects were asked to rate the severity of gastrointestinal symptoms on a seven-point Likert scale (1 = absent; 2 = minor; 3 = mild; 4 = moderate; 5 = moderately severe; 6 = severe and 7 = very severe). In analysis a score of ≥2 was defined as symptom presence and ≥4 was defined as moderate symptom presence. Lower GIS were classified as gas/flatus, bloating, diarrhoea, and urgent need to defecate and upper GIS as nausea, heartburn, acid reflux, hunger, burping.

2.4. Statistical Analysis {#sec2dot4-nutrients-10-00811}
-------------------------

Descriptive statistics (mean ± SD (standard deviation)) were calculated for all variables. Differences between symptomatic and asymptomatic runners were analysed using unpaired *t*-tests. As GIS showed non-normal distributions a non-parametric approach to analysing associations with nutritional intake was used. Further, non-parametric analyses has previously been used in investigations that examined predictors of GI distress during exercise. Nutritional intake and gastrointestinal problems during competitive endurance events \[[@B2-nutrients-10-00811],[@B19-nutrients-10-00811],[@B20-nutrients-10-00811]\]. Spearman's rank correlation was used when GIS were considered. *p* \< 0.05 was considered statistically significant. Based on a Mann--Whitney U test, no differences in total GIS (summed score from GSRS) were apparent between males and females (Z = −1.14, *p* = 0.25) nor between participants in both races (Z = −0.068, *p* = 0.946). Thus, correlations were carried out with all participants combined. A two-sided *p*-value ≤0.05 was used as the threshold for statistical significance.

3. Results {#sec3-nutrients-10-00811}
==========

Mean time to complete the marathon in each race was 260 (176--361) and 236 (183--278) min, for the Liverpool and Dublin marathon, respectively. Training data are shown in [Table 1](#nutrients-10-00811-t001){ref-type="table"}, and nutritional data are shown in [Table 2](#nutrients-10-00811-t002){ref-type="table"} and [Table 3](#nutrients-10-00811-t003){ref-type="table"}.

[Table 4](#nutrients-10-00811-t004){ref-type="table"} shows the prevalence of any symptoms (score ≥2) and any moderate symptoms (score ≥4). From both races, 41% and 47% of participants reported at least one moderate symptom during the previous 7 days, while 30% and 20% reported experiencing moderate symptoms during the race for Liverpool and Dublin marathon respectively.

To identify potential associative factors, GIS scores were summed to give lower, upper and total GIS scores. Correlations between symptoms during the race and all nutritional factors were low and insignificant (*r* \< 0.20, *p* \> 0.05). There were significant correlations between symptoms in the 7 days prior to the race and during the race for total GIS score (*r* = 0.510, *p* \< 0.001), upper GIS score (*r* = 0.346, *p* = 0.001) and lower GIS score (*r* = 0.483, *p* \< 0.001).

4. Discussion {#sec4-nutrients-10-00811}
=============

The current study assessed the incidence and severity of numerous GIS, using a previously validated questionnaire to document the dietary intake and GIS during training in the week before a marathon and during a marathon in order to explore potential predictive factors of GIS. Our data indicate that there is a significant prevalence of moderate GIS in the week leading to a marathon race, and during the race amongst recreational runners. We show that 42% of participants reported moderate GIS in the 7 days prior to the marathon and 27% reported moderate symptoms during the marathon with most common symptoms being flatus (16%) during training, and nausea (8%) during the marathon race. However, it was found that there was no association between nutritional intake and symptoms, neither in the 24 h prior to, during the meal before, nor during the race.

Gastrointestinal symptoms during endurance competitions have been previously reported by 4--96% of participants \[[@B1-nutrients-10-00811]\]. Differences between studies could be due to a number of factors such as exercise intensity or duration, and environmental temperatures, which have been shown to exacerbate gastrointestinal damage and increase symptoms \[[@B1-nutrients-10-00811],[@B2-nutrients-10-00811],[@B7-nutrients-10-00811],[@B21-nutrients-10-00811]\]. Variances may also arise from the questionnaires used, the symptoms that are included, and the criteria for classifying a symptom. Studies that have reported data for GIS in marathon runners, without acknowledging severity, have shown prevalence rates of 52% and 71% \[[@B6-nutrients-10-00811],[@B7-nutrients-10-00811]\], while 'moderate' or 'serious' GIS prevalence has been reported as 4--7% \[[@B2-nutrients-10-00811],[@B3-nutrients-10-00811]\]. In the present study, 70% of participants reported having any symptoms, while only 27% had symptoms recorded as moderate or worse, with nausea being the most common (12% of all runners). This highlights the need to differentiate symptom severity within studies, as well as the specific symptom, as these may have different aetiologies, and therefore require different interventions for attenuation. Future studies should ensure pathology is excluded (bloods and faecal calprotectin, endoscopy etc.) and psychological factors, along with validating symptoms against Rome III or IV diagnostic criteria for irritable bowel syndrome. We have, however, made some distinction between exertion related symptoms and nutritional factors.

Gastrointestinal symptoms have been shown to relate to higher CHO intake, higher fat intake, and, in particular, lower fluid consumption during ultra-distance events of longer duration \[[@B2-nutrients-10-00811],[@B22-nutrients-10-00811]\]. However, this has not been as clear in marathon running or events of shorter durations \[[@B2-nutrients-10-00811],[@B23-nutrients-10-00811]\]. Here, there was no correlation between total, upper or lower GIS scores and any nutritional factor recorded. This includes dietary intake in the 24 h prior to the race, breakfast on race-day, or in-race nutrition. The difference may be due to the duration of the event. For example, it has been shown that the majority of symptoms during ultra-distance running events did not occur until after 50 km of running and coincided with greater reductions in body weight, attributed to dehydration \[[@B4-nutrients-10-00811],[@B22-nutrients-10-00811]\]. If euhydration is maintained, GIS may be less prevalent, as has been found in events lasting even up to and beyond 24 h \[[@B24-nutrients-10-00811]\]. Longer duration events, and therefore greater total dietary intake, has also been proposed to increase the likelihood of CHO malabsorption \[[@B10-nutrients-10-00811],[@B25-nutrients-10-00811]\]. However, with the recorded CHO intakes during the marathon (mean of 0.4 g·min^−1^), this was unlikely to be seen here. While not the primary aim of the present study, it should be noted that the mean values for CHO intake both before and during the race were below those recommended for marathon performance \[[@B26-nutrients-10-00811]\]. This nutritional intake data is in close agreement with previous studies in marathon runners \[[@B27-nutrients-10-00811],[@B28-nutrients-10-00811]\]. Recreational runners' performance could therefore be improved with appropriate CHO intake. As no association was observed here between nutritional intake and GIS, some other factors, not assessed here may contribute to the prevalence of GIS found.

Gastrointestinal symptoms are often more prevalent during marathon running and other endurance events in individuals with a history of symptoms \[[@B2-nutrients-10-00811],[@B7-nutrients-10-00811],[@B22-nutrients-10-00811]\]. The results here showed a large correlation between symptom scores during the 7 days before the race and during the race. This corroborates previous study findings and may be due to a number of factors. These individuals may consistently be those becoming dehydrated, they may have some underlying pathology, or they may experience greater levels of stress and/or anxiety which has been shown to increase gastrointestinal symptomology \[[@B20-nutrients-10-00811]\].

A limitation of the present study is the use of food diaries to analyse nutritional habits, and indeed, previous research has shown a potential under-reporting effect of up to 20% \[[@B29-nutrients-10-00811]\]. It is possible that macronutrient, fibre, and fluid intakes reported have been under-estimated. However, total calories and CHO intake reported here are in close agreement with previous studies in marathon runners \[[@B27-nutrients-10-00811],[@B28-nutrients-10-00811]\]. It should also be noted that a reduction in fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) intake has recently been shown to alleviate GIS in endurance athletes \[[@B30-nutrients-10-00811]\]. However, FODMAP content was not quantified here, and this may have been a factor associated with symptoms seen in the current study. Additionally, both marathon races included here had over 20,000 participants combined, yet only 216 runners registered to participate, with 96 of these runners completing the online questionnaires to sufficient detail to be included in the dataset. Therefore, the results could be liable to non-response bias \[[@B31-nutrients-10-00811]\] raising the possibility that the data are exaggerating the prevalence of GIS, particularly if those who experience symptoms had more interest in the research project, and therefore were more likely to participate in a related study. Finally, as with any study of an observational nature, there are other confounding variables, otherwise not accounted for, whilst it is also difficult to draw any conclusions of cause-and-effect.

5. Conclusions {#sec5-nutrients-10-00811}
==============

The current study has identified a high prevalence of GIS in recreational runners, both in training in the week prior to a marathon and during marathon running. The most common symptoms were flatus and nausea during training and marathon running, respectively. In this population of runners, there was no clear association between any nutritional factors and symptoms. However, there was a significant correlation between symptoms during training, and symptoms during the marathon. The current study highlights the need to further quantify not only the prevalence, but also the potential aetiology of GIS to develop interventions that may attenuate symptoms. This may then lead to increased athletic performance, quality of life, and health.

Conceptualization, J.N.P. and G.L.C.; Methodology, J.N.P., R.F. and G.L.C.; Formal Analysis, J.N.P., B.K. and J.P.M.; Investigation, J.N.P.; Data Curation, J.N.P. and J.P.M.; Writing-Original Draft Preparation, J.N.P. and B.K.; Writing-Review & Editing, J.N.P., J.P.M. and G.L.C.; Supervision, J.P.M. and G.L.C.

The study was funded by a research grant funded by Aliment Nutrition, awarded to G.L.C.

The authors declare no conflict of interest.\"

nutrients-10-00811-t001_Table 1

###### 

Subject characteristics of recreational marathon runners (values are mean ± standard deviation (SD)).

                                            Liverpool Marathon (*n* = 66)   Dublin Marathon (*n* = 30)
  ----------------------------------------- ------------------------------- ----------------------------
  Age (years)                               43.4 ± 9.5                      42.3 ± 8.8
  Weight (kg)                               70.4 ± 12.5                     66.1 ± 11.7
  Height (cm)                               163.7 ± 36.7                    163.7 ± 34.0
  Number of previous marathons              7 ± 10                          15 ± 29
  Quickest marathon in last 2 years (min)   245.7 ± 42.0                    238.2 ± 29.4
  Highest weekly mileage                    41.5 ± 14.3                     46.7 ± 14.6
  Longest single training run (miles)       20.4 ± 4.8                      20.4 ± 3.5

nutrients-10-00811-t002_Table 2

###### 

Nutritional intake on the day before the race and during the race-day breakfast.

  Nutritional intake           Day Before Race   Race-day Breakfast               
  ---------------------------- ----------------- -------------------- ----------- -----------
  Total Energy Intake (Kcal)   2329 ± 775        1987 ± 692           552 ± 316   436 ± 251
  CHO (g)                      262 ± 93          262 ± 120            76 ± 45     59 ± 41
  CHO (g·kg^−1^)               3.8 ± 1.4         3.4 ± 2.5            1.1 ± 0.9   0.8 ± 0.8
  Sugars (g)                   89 ± 57           100 ± 74             39 ± 29     27 ± 25
  Starch (g)                   168 ± 66          148 ± 63             36 ± 30     34 ± 21
  Fibre (g)                    22 ± 9            21 ± 8               6 ± 4       6 ± 5
  Protein (g)                  98 ± 39           85 ± 41              19 ± 12     13 ± 8
  Protein (g·kg^−1^)           1.4 ± 0.8         1.1 ± 0.8            0.3 ± 0.2   0.2 ± 0.2
  Fat (g)                      95 ± 52           66 ± 36              17 ± 18     18 ± 36
  Saturated fat (g)            34 ± 17           22 ± 14              7 ± 8       4 ± 4
  Sodium (mg)                  2478 ± 1434       1937 ± 1094          436 ± 402   304 ± 281
  Water (mL)                   2672 ± 1369       2110 ± 1057          795 ± 598   443 ± 306

nutrients-10-00811-t003_Table 3

###### 

Nutritional intake during the marathon race.

  Nutritional intake           During the Race   
  ---------------------------- ----------------- --------------
  Total Energy Intake (Kcal)   439 ± 277         540 ± 312
  CHO (g)                      100.9 ± 60.1      126.3 ± 64.1
  CHO (g·min^−1^)              0.4 ± 0.2         0.4 ± 0.3
  Sugars (g)                   37.2 ± 31.8       36.6 ± 34.2
  Starch (g)                   64.2 ± 45.9       72.4 ± 55.8
  Fibre (g)                    1.0 ± 2.8         2.3 ± 4.6
  Protein (g)                  2.4 ± 6.5         4.3 ± 7.9
  Fat (g)                      1.4 ± 3.6         3.3 ± 5.8
  Saturated fat (g)            0.4 ± 1.1         0.8 ± 1.5
  Sodium (mg)                  259 ± 268         286 ± 323
  Water (mL)                   1390 ± 765        1149 ± 693

CHO: carbohydrate.

nutrients-10-00811-t004_Table 4

###### 

Prevalence of individual symptom scores (≥2) and moderate (≥4) symptoms. Data are percentage of participants in each race.

                            Liverpool Marathon (*n* = 66)   Dublin Marathon (*n* = 30)        
  ------------------------- ------------------------------- ---------------------------- ---- ---
  Nausea                    32                              17                           18   2
  Heartburn                 8                               5                            2    2
  Acid Reflux               9                               2                            3    0
  Hunger                    18                              3                            12   5
  Burping                   30                              8                            11   2
  Bloated                   24                              11                           5    0
  Gas/Flatus                30                              9                            14   2
  Diarrhoea                 15                              8                            5    2
  Urgent need to defecate   20                              9                            5    2
